Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: £6.47 M
• Last 12 months FTD volume: £21.79 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	£56.21 M	£0.12 B	🇺🇸 USA
Thermo Fisher Scientific TMO	£8.2 M	£70.05 M	🇺🇸 USA
General Electric GE	£16.57 M	£0.51 B	🇺🇸 USA
Bristol-Myers Squibb BMY	£31.05 M	£81.93 M	🇺🇸 USA
Sangamo Therapeutics SGMO	£0.39 M	£8.1 M	🇺🇸 USA
Novavax NVAX	£15.56 M	£63.4 M	🇺🇸 USA
Neurocrine Biosciences NBIX	£5.02 M	£30.19 M	🇺🇸 USA
Bio-Techne TECH	£9.3 M	£18.92 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£8.34 M	£13.64 M	🇺🇸 USA
Charles River Laboratories CRL	£84.22 M	£0.15 B	🇺🇸 USA